Navigation Links
Valeant Pharmaceuticals Reports 2011 First Quarter Financial Results
Date:5/9/2011

MISSISSAUGA, Ontario, May 9, 2011 /PRNewswire/ --

  • 2011 First Quarter Total Revenue $565 million, including $36 million related to out-license of Cloderm
  • Pro forma organic growth for the combined company, excluding the impact of foreign exchange and acquisitions, was approximately 7%
  • Excluding impact from Diastat and Efudex, pro forma organic growth for the combined company was approximately 11%
  • 2011 First Quarter GAAP EPS $0.02; Cash EPS $0.62
  • Excluding impact from Cloderm out-licensing, Cash EPS was $0.56
  • 2011 First Quarter GAAP Cash Flow from Operations was $86 million; Adjusted Cash Flow from Operations was $204 million  
  • 2011 Guidance increased to $2.65 - $2.90 Cash EPS

    • Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) announces first quarter financial results for 2011.

    "Our performance in the first quarter is a strong start to what I believe will be another successful year for Valeant," said J. Michael Pearson, chairman and chief executive officer.  "Our specialty businesses performed well and our branded generic operations, in particular Central Europe, exceeded our expectations this quarter.  This strong performance is a testament to our diversified business model that gives us the ability to pursue acquisition opportunities, while continuing to deliver strong operating results."

    RevenueTotal revenue was $565.0 million in the first quarter of 2011 as compared to $219.6 million in the first quarter of 2010.  Included in total revenue was $36.0 million of alliance and royalty revenue related to the out-license of product rights for Cloderm, a mid-potency steroid with an annual revenue run rate of approximately $7 million, that was completed on March 31, 2011.  Product sales were $500.4 million in the fi
    '/>"/>

    SOURCE Valeant Pharmaceuticals International, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

    Related medicine technology :

    1. Valeant to Acquire Polish Products
    2. GSK and Valeant Announce New U.S. FDA PDUFA Goal Date for Ezogabine
    3. Valeant and Biovail Announce Results of Special Meetings of Shareholders
    4. Valeant Pharmaceuticals Announces Redemption and Defeasance of 7.625% Senior Notes Due 2020 and 8.375% Senior Notes Due 2016
    5. Valeant Pharmaceuticals Announces That Alexza Pharmaceuticals Has Received a Complete Response Letter for AZ-004 (Staccato® Loxapine) Inhalation Aerosol NDA
    6. Valeant Pharmaceuticals Reports 2010 Third Quarter Financial Results
    7. Valeant Declares Special Dividend and Plans to Create a Special Dividend Reinvestment Plan
    8. Valeant Announces Pricing of Senior Notes
    9. Valeant Pharmaceuticals Announces Appointment of Robert A. Ingram and Resignation of William M. Wells as Chairman
    10. Valeant Pharmaceuticals Appoints Philip W. Loberg as Interim CFO
    11. Regulatory Update - GSK and Valeant Receive Positive Opinion in Europe From the CHMP for Trobalt (Retigabine)
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/22/2013)... May 22, 2013 /PRNewswire-iReach/ -- MarketReportsOnline.com announces addition ... Guidebook Series (4) 2013 Edition Material and Clinical ... Drug Registration: A Guidebook of Registration Application for ... to its online database. The traditional ... are always regarded by occidental as mysterious medicines. ...
    (Date:5/22/2013)... VANCOUVER, British Columbia , May 22, 2013  OncoGenex ... the development of novel therapeutics to target mechanisms of treatment ... investigational compounds, custirsen and OGX-427, will be presented as "Trials ... of the American Society of Clinical Oncology (ASCO) in ... 4. Despite the availability of drugs that ...
    (Date:5/21/2013)... 2013 Concord Medical Services Holdings Limited ("Concord ... a leading specialty hospital management solution provider and operator ... centers in China and the parent of Chang,an Hospital, ... first quarter ended March 31, 2013 [1] . ... revenue, which consists of net revenues generated from the ...
    Breaking Medicine Technology:China Pharmaceutical Market Guidebook Series (4) 2013 Report 2China Pharmaceutical Market Guidebook Series (4) 2013 Report 3China Pharmaceutical Market Guidebook Series (4) 2013 Report 4China Pharmaceutical Market Guidebook Series (4) 2013 Report 5OncoGenex Announces Multiple 'Trials in Progress' Presentations at the 2013 ASCO Annual Meeting 2OncoGenex Announces Multiple 'Trials in Progress' Presentations at the 2013 ASCO Annual Meeting 3OncoGenex Announces Multiple 'Trials in Progress' Presentations at the 2013 ASCO Annual Meeting 4OncoGenex Announces Multiple 'Trials in Progress' Presentations at the 2013 ASCO Annual Meeting 5Concord Medical Reports First Quarter 2013 Financial Results 2Concord Medical Reports First Quarter 2013 Financial Results 3Concord Medical Reports First Quarter 2013 Financial Results 4Concord Medical Reports First Quarter 2013 Financial Results 5Concord Medical Reports First Quarter 2013 Financial Results 6Concord Medical Reports First Quarter 2013 Financial Results 7Concord Medical Reports First Quarter 2013 Financial Results 8Concord Medical Reports First Quarter 2013 Financial Results 9Concord Medical Reports First Quarter 2013 Financial Results 10Concord Medical Reports First Quarter 2013 Financial Results 11Concord Medical Reports First Quarter 2013 Financial Results 12Concord Medical Reports First Quarter 2013 Financial Results 13
    ... 28, 2011 Pharmasset, Inc. (Nasdaq: VRUS ) ... Conference being held May 2 to 4, 2011 at the ... Merrill Lynch Healthcare Conference being held May 10 to 12, ... Price, Pharmasset,s President and Chief Executive Officer, will provide an ...
    ... 28, 2011 The U.S. Food and Drug ... with prednisone (a steroid) to treat patients with ... prior docetaxel (chemotherapy). (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ... sex hormone testosterone stimulates prostate tumors to grow. ...
    Cached Medicine Technology:Pharmasset to Present at Two Upcoming Investor Conferences 2Pharmasset to Present at Two Upcoming Investor Conferences 3FDA Approves Zytiga for Late-Stage Prostate Cancer 2FDA Approves Zytiga for Late-Stage Prostate Cancer 3
    (Date:5/22/2013)... Brigham and Women,s Hospital (BWH) finds that a genetic ... lung disease, may be effective in identifying individuals at ... presented at the American Thoracic Society International Conference and ... of Medicine on May 22 and will appear ... variant of the MUC5B gene is fairly common, pulmonary ...
    (Date:5/22/2013)... of Prussia, PA (PRWEB) May 22, 2013 ... proud to announce its participation in the Greater Philadelphia Tour ... cyclists and recreational riders who are passionate about stopping the ... more than 25 million Americans. , The Tour de ... Campus, located at 580 Meetinghouse Road in Ambler, 30 minutes ...
    (Date:5/22/2013)... CA (PRWEB) May 22, 2013 Following ... the fitness franchise Fit Body Boot Camp ... Annual 1,000 lb. Meltdown Challenge starting on June 3rd ... Davidson Centre 601 Durham Street, Kincardine, Ontario.     , Fit ... to inspire and motivate local community residents to lose ...
    (Date:5/22/2013)... BroadConnect Telecom, the leading provider ... solutions in North America announced plans to increase ... BroadConnect hosted security solutions. Available on premise, from ... new Security as a Service (SaaS) enables business ... of their choice, while optimizing internal network security. ...
    (Date:5/22/2013)... Those who have already gone through a lap ... hardest work is yet to come. As of April 24, ... have special health needs that should be addressed in nutrition ... Surgery” abclocal.go.com/kabc/story?section=news/food_coach&id=9078455). Bariatric surgeon Dr. Madan offers four tips to ... can be lost and kept off. , First, lap ...
    Breaking Medicine News(10 mins):Health News:Genetic marker associated with risk for pulmonary fibrosis 2Health News:PreDiabetes Centers to Appear at the Philadelphia Tour de Cure 2Health News:PreDiabetes Centers to Appear at the Philadelphia Tour de Cure 3Health News:Kincardine Fitness Center Promotes 2nd Annual 1,000 lb. Meltdown Challenge to Fight Obesity With All Proceeds Raised Going to Local Charity 2Health News:Kincardine Fitness Center Promotes 2nd Annual 1,000 lb. Meltdown Challenge to Fight Obesity With All Proceeds Raised Going to Local Charity 3Health News:BroadConnect Telecom to Launch Enterprise-Grade Hosted Security Solutions Engineered to Meet the Demands of Real World Business 2Health News:The Lap Band Center: Dr. Atul Madan Offers Five Tips for Ongoing Weight Loss for Lap Band Patients 2Health News:The Lap Band Center: Dr. Atul Madan Offers Five Tips for Ongoing Weight Loss for Lap Band Patients 3
    ... teach that selflessly "doing unto others" brings rewards in the hereafter. ... A growing body of research shows that religious practices are, ... will be outlined more fully at an extraordinary one-day conference, "Religious ... , Sponsored by The Heritage Foundation ...
    ... about eating healthfully, they make healthy foods, too. Members of ... practice group participated in a 2008 "Fast, Fresh & Flavorful" ... the top three submissions that were both healthy and delicious. ... the contest recipes were that they must include at least ...
    ... Rick Warren will present President,George W. Bush with the first ... of his unprecedented contribution to the fight,against HIV/AIDS and other ... held at the Newseum in Washington, D.C. on World AIDS,Day, ... the Forum, Warren will engage both President Bush and Mrs. ...
    ... 2008 as a free alternative to fee-based patent searching services, has rolled ... ... (Business Wire EON) November 24, 2008 -- SumoBrain is free to ... documents in Adobe PDF format by entering a list of up to ...
    ... decade Ochsner Health System,has enjoyed a partnership with Surgical ... cost savings and increased revenues for,Ochsner,s surgical services. ... more than their share of tragedy. Natural disasters ... New Orleans hospital infrastructure,badly damaged. Ochsner Medical Center ...
    ... Nov. 24 A study released recently in the,British ... 140 men who,received care at Washington University ... University of Michigan . The study, titled "Evaluation of ... found that,TargetScan(R) template guided biopsy technology potentially produces a ...
    Cached Medicine News:Health News:Conferees to Explore How Religious Practice Reaps Health 2Health News:Conferees to Explore How Religious Practice Reaps Health 3Health News:Three Chef-Dietitians Win CanolaInfo Recipe Contest 2Health News:Saddleback Civil Forum on Global Health to Honor President George W. Bush on World AIDS Day: 2Health News:Saddleback Civil Forum on Global Health to Honor President George W. Bush on World AIDS Day: 3Health News:Saddleback Civil Forum on Global Health to Honor President George W. Bush on World AIDS Day: 4Health News: SumoBrain Adds Bulk PDF Downloading : Free Service Saves Money and Time for Attorneys, Inventors and Corporate IP Professionals 2Health News:Ochsner Health System, Surgical Information Systems Partner to Rebuild New Orleans Healthcare Infrastructure 2Health News:Ochsner Health System, Surgical Information Systems Partner to Rebuild New Orleans Healthcare Infrastructure 3Health News:TargetScan Evaluation is Shown to Deliver Potentially Higher Cancer Detection Rate and More Accurate Assessment of Grade 2
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    Medicine Products: